SAN FRANCISCO, Dec. 19 (Xinhua) -- A new study led by researchers at the Stanford University School of Medicine indicates that profiling the genes of lung-tumor cells from patient blood samples may be a cheap, noninvasive way to help doctors choose the right treatments.
The researchers created a system for isolating circulating tumor cells from the blood of cancer patients and reading a handful of genes from inside each tumor cell, enabling them to obtain genetic information about the original cancer tumor that resides deep in the lungs without doing a biopsy, which can be dangerous for the patient.
It is common for cancer therapies to fail after a few months, often because the cancer evolves resistance to the treatment. At that point, "without a biopsy and genetic profiling, we are flying blind, trying to select a second or third option for therapy and hoping it works," said radiology instructor Seung-min Park, a lead author of the study published online in the Proceedings of the National Academy of Sciences. But repeated lung biopsies are too hard on patients.
Finding a way to look at circulating tumor cells, or CTCs, in the blood has been a goal of oncologists for years. When people die of cancer, it is usually from metastasis, the spread of tumors throughout the body. Part of metastasis is the entry of tumor cells into the bloodstream, where they circulate along with normal blood cells, eventually landing in other organs and initiating tumors there.
"This work fits well into our bigger vision of using blood-based diagnostics to detect and manage disease, including cancer," said Sanjiv "Sam" Gambhir, professor and chair of radiology. "By being able to characterize single CTCs, we believe cancer management, including predicting response to therapy, will be much better optimized."
The blood typically contains very few CTCs, so one of the challenges has been to separate them from ordinary blood cells. The new technique involves taking blood from lung cancer patients and then attaching antibodies to circulating tumor cells. Once the cancer cells are labeled, the team introduces magnetic nanoparticles designed to attach to the antibodies labeling the cancer cells.
With each individual cancer cell labeled with a magnetic nanoparticle, the researchers can then use a device called a magnetic sifter, or MagSifter, previously developed by Shan Wang, Stanford professor of materials science and engineering and of electrical engineering.
When the MagSifter is on, it pulls the nanoparticle-labeled CTCs from the blood sample and allows the rest of the blood to flow through the sifter. The CTCs pulled from the blood are then deposited into a flat array of tiny wells, each large enough for only one cell. Now the tumor cells are ready for genetic analysis.
In principle, the technique should work just as well with other kinds of cancers, said former Stanford graduate students Dawson Wong. "We validated our device on lung cancer because of the difficulties of doing lung biopsies," he was quoted as saying in a news release. "But the technology is not limited to profiling lung cancer. We could swap out markers and adapt the technique to other types of cancers."
The approach could be used to look at mutations in three or four genes, and it requires no more than 2 milliliters of blood, or about half a teaspoon. The test can be completed in about five hours, the researcher said, and costs less than 30 U.S. dollars.
GRE阅读:长句、难句重磅解析(21)
GRE阅读答题全过程
想得GRE阅读高分应加强哪些方面的练习?
译文 GRE阅读36套(二十五)
其实,新GRE阅读文章应该这么读!
GRE阅读考试的主体,细节与写作手法串讲
注意GRE阅读中一些长句的语法结构
GRE阅读出题难点实例解析
GRE阅读:长句、难句重磅解析(13)
GRE阅读:长句、难句重磅解析(18)
GRE快速阅读时需要注意哪些问题?
你不可不知的GRE阅读潜规则
ETS是如何考察GRE文章内部的复杂逻辑的
GRE阅读:词汇的准备+句子理解的准备
“外国背景知识”是GRE阅读高分的筹码!
GRE考试中的阅读文章是怎么设计的?
GRE阅读:长句、难句重磅解析(31)
GRE阅读长难句分类
GRE阅读:长句、难句重磅解析(26)
你知道GRE阅读的这些得分点吗?
GRE阅读:长句、难句重磅解析(17)
GRE阅读:长句、难句重磅解析(32)
GRE阅读中遇到的难题该怎么解决
GRE阅读:长句、难句重磅解析(19)
GRE阅读:长句、难句重磅解析(22)
GRE阅读:长句、难句重磅解析(30)
GRE阅读:长句、难句重磅解析(20)
针对新GRE阅读改革,考生们如何突破高分?
译文 GRE阅读36套(二十二)
那些年我们一起用过的GRE阅读技巧
不限 |
英语教案 |
英语课件 |
英语试题 |
不限 |
不限 |
上册 |
下册 |
不限 |